Healthcare & Life Sciences
CFDX
alivepre-seed
pre-seed
Stage
1
Investors
About
CFDX develops liquid biopsy-based methods and disease vector generation tools to study and characterize early-stage diseases, with a particular focus on neurodegeneration.
Explore CFDX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.